Likes Subject
Motion for Alternative Victim Notification Granted! pumper_stumper 03/18/22 8:46 AM
WHY THATS HYWAY ROBBERY ernie44 02/05/23 3:31 PM
This means that the prosecution WILL get access IPwatcher 02/03/23 8:16 PM
GALL darn criminals anyway !!!!!!!!!!!!!!!! ernie44 02/03/23 11:55 AM
I Plead the SEC halts trading until after
Bullish
Bullish
ernie44 02/01/23 12:11 PM
The defendant shall return the financial affidavit to IPwatcher 01/31/23 2:15 PM
Points well-taken and are quite rational. LOL! rawman 01/31/23 12:16 PM
Do you know if the FA is considered IPwatcher 01/31/23 12:13 PM
For those who have watched this clown for rawman 01/31/23 11:42 AM
Berman going for broke.... IPwatcher 01/31/23 10:50 AM
Hearing scheduled this Friday! IPwatcher 01/25/23 6:27 PM
Sparse trading---why--the chickens cross the wrong road ???????????????????????? ernie44 01/23/23 4:55 PM
How does the Court extend a six-month extension IPwatcher 01/12/23 11:30 AM
WE certainly hope so............................................................ ernie44 01/12/23 10:34 AM
How does the Court extend a six-month extension diarch 01/12/23 8:16 AM
Is Berman in jail yet? I havent checked IPwatcher 01/12/23 7:49 AM
Is Berman in jail yet? I havent checked BostonSportsNut 01/12/23 6:11 AM
it will be interesting to see who and ernie44 01/08/23 1:47 AM
And you IPW! We are in dire need diarch 01/07/23 9:31 AM
And you IPW! We are in dire need diarch 01/07/23 9:31 AM
Speaking of hotels- who will check in to IPwatcher 01/05/23 6:41 PM
Haven't checked in for weeks, as likely months. diarch 01/05/23 3:44 PM
Interesting. Ascertainment of Counsel Hearing scheduled for 27th IPwatcher 12/24/22 1:17 PM
One would hope the Feds dig very deeply IPwatcher 12/13/22 10:47 AM
Good news--the court will find how he does
Bullish
Bullish
ernie44 12/12/22 12:43 PM
One would hope the Feds dig very deeply rawman 12/12/22 9:33 AM
Hey... Berman just got handed a Court backed IPwatcher 12/10/22 6:18 PM
lotsa talk , but no action
Bullish
Bullish
ernie44 12/10/22 10:59 AM
He always had such a way with words. pumper_stumper 12/09/22 7:44 PM
A "stupid" person who creates a crime is IPwatcher 12/09/22 7:24 PM
Yo Rawman. Godo to hear from you again. IPwatcher 12/09/22 1:18 PM
Hi IP! It's been awhile. I rawman 12/09/22 12:32 PM
Well said! I ll be back 12/09/22 9:51 AM
Actually, you were correct on the crook. As IPwatcher 12/08/22 7:20 PM
Last I heard, the office was closed. IPwatcher 12/08/22 7:09 PM
Wise investor! I ll be back 12/08/22 7:04 PM
You can book on the fact that they IPwatcher 12/08/22 6:52 PM
Sorry, I have no idea. I ll be back 12/08/22 6:35 PM
I had the good fortune of meeting Spanky I ll be back 12/08/22 6:31 PM
Is he mainly at Thousand Oaks for his IPwatcher 12/08/22 4:49 PM
Is he mainly at Thousand Oaks for his pumper_stumper 12/08/22 4:20 PM
Let's just say I happen to know him IPwatcher 12/08/22 4:15 PM
Agreed. Let's just say I happen to know him I ll be back 12/08/22 3:10 PM
Regarding your two options. There is a third IPwatcher 12/08/22 3:03 PM
IP, good eye. I ll be back 12/08/22 2:57 PM
On consideration, there is a 3rd and 4th possibility: IPwatcher 12/08/22 2:54 PM
My interest was piqued that Berman parted ways IPwatcher 12/08/22 2:36 PM
Interesting. The fact that KB didn't show up to I ll be back 12/08/22 2:03 PM
No surprise here, thanks for confirming. I ll be back 12/08/22 1:56 PM
I don't understand the "lack of meaningful financial IPwatcher 12/08/22 9:16 AM
Good info. I only had the patience pumper_stumper 12/08/22 7:24 AM
Likes Subject

pumper_stumper
03/18/22 8:46 AM
ernie44
02/05/23 3:31 PM
ernie44
02/01/23 12:11 PM
IPwatcher
01/31/23 12:13 PM
IPwatcher
01/31/23 10:50 AM
IPwatcher
01/25/23 6:27 PM
IPwatcher
01/12/23 7:49 AM
BostonSportsNut
01/12/23 6:11 AM
ernie44
01/08/23 1:47 AM
diarch
01/07/23 9:31 AM
diarch
01/07/23 9:31 AM
IPwatcher
01/05/23 6:41 PM
IPwatcher
12/13/22 10:47 AM
ernie44
12/12/22 12:43 PM
rawman
12/12/22 9:33 AM
ernie44
12/10/22 10:59 AM
pumper_stumper
12/09/22 7:44 PM
IPwatcher
12/09/22 7:24 PM
IPwatcher
12/09/22 1:18 PM
rawman
12/09/22 12:32 PM
I ll be back
12/09/22 9:51 AM
IPwatcher
12/08/22 7:20 PM
IPwatcher
12/08/22 7:09 PM
I ll be back
12/08/22 7:04 PM
IPwatcher
12/08/22 6:52 PM
I ll be back
12/08/22 6:35 PM
I ll be back
12/08/22 6:31 PM
IPwatcher
12/08/22 4:49 PM
pumper_stumper
12/08/22 4:20 PM
IPwatcher
12/08/22 4:15 PM
I ll be back
12/08/22 3:10 PM
I ll be back
12/08/22 2:57 PM
I ll be back
12/08/22 2:03 PM
I ll be back
12/08/22 1:56 PM
pumper_stumper
12/08/22 7:24 AM

Decision Diagnostics Corp. (DECN)

Followers
398
Posters
Posts (Today)
0
Posts (Total)
96868
Created
04/18/05
Type
Free
Moderators pumper_stumper ernie44

 

     $DECN       
https://www.otcmarkets.com/stock/DECN/profile

                                                          

On December 18, 2020, the SEC and US Dept of Justice, announced actions against DECN due to alledged false claims about the supposed Covid-19 test being developed.

https://www.sec.gov/litigation/complaints/2020/comp-pr2020-327.pdf

On April 23, 2020, the SEC announced an action against DECN, suspending trading in the company's stock for two weeks.  There is currently a SEC court case ongoing where the SEC has identified the many reasons for the suspension.

https://www.otcmarkets.com/stock/DECN/news/SEC-Suspension-of-Trading?id=260085


Motion for Alternative Victim Notification Granted!

MINUTE ORDER granting the Government's 88 Motion for Victim Rights. The Government may provide notice to potential crime victims in this case through publication on a website maintained by the Department of Justice as an alternative to providing individualized notice. SO ORDERED. Signed by Judge Trevor N. McFadden on 3/17/2022.

ALTERNATIVE VICTIM NOTIFICATION PROCEDURES

The United States, through undersigned counsel, respectfully moves for authorization to use alternative victim notification procedures— namely, publication on a Department of Justice website—because the large number of potential crime victims in this case makes it impracticable to notify them on an individualized basis.

The website would provide a summary of the case, information regarding the case’s status, and other significant case-related documents, such as the charging documents. The website also would contain an e-mail address
and telephone number for a Victim Assistance Line through which individual potential crime victims could contact the Department of Justice with questions regarding the case.

https://www.justice.gov/criminal-vns/case/decision-diagnostics


 

DECN Earnings History

2021 Q1-Q3 - $1,374,707
  2020 - $
29,668,622-
2019 - $
3,132,295-
2018 - $2,240,220-
2017 - $2,991,404-
2016 - $2,967,357-
2015 - $2,771,345-
2014 - $1,841,010-

Total - $46,986,960-



                                     
Decision Diagnostics Corp. is a nationwide prescription and non-prescription diagnostics and home testing products distributor. We market our GenUltimate, GenSure, PetSure (test strips for dogs and cats) and GenChoice (in FDA 510(k) review), our panacea GenUltimate TBG glucose test strips and meter (in 3rd party testing), our GenPrecis test strips and meter (for private label sale), and our GenUltimate 4Pets glucose test strips and meter for the diabetic testing of dogs, cats and horses. We are also FDA approved and have complete R&D and manufacturing facilities in South Korea. We made the the first alternative glucose testing strips sold to the market in this decade and the first alternative test strip products sold into the market since early 2008.

                                                                                             
                                                                        



                                      

                                                                                                
               

Keith Berman, CEO of DECN commented, "GenViro for the Coronavirus (covid19) began as an outgrowth of our GenUltimate TBG product line. What makes the testing for the Coronavirus possible, and the GenUltimate TBG special, is the company's Impedance measurement technology.

https://www.frontiersin.org/articles/10.3389/fmicb.2015.00940/full

While infectious disease testing and management has not previously been a part of our business model, we seized on this "do good" opportunity because our "Gen" line of products are and have been manufactured since 2016 in what is ground zero for Coronavirus (covid19) in Daegu, Korea. The company will have available samples of the blood of those previously infected available for testing as the company quickly converts its GenUltimate TBG methods and Precise meter, into a precise infectious disease testing device for the screening for Coronavirus."

                                                    



Read Recent Press Releases » 

Review Recent Financial Reports »

Visit PharmaTech Solutions, Inc. »

                                 

 


Mod Cash4 Updated Ibox 3/11/2020

NEWS
https://www.otcmarkets.com/stock/DECN/news


 

GenViro! 12-Month Forecast

Number of Months

1

2

3

4

5

6

7

8

9

10

11

12

SUM

Year 1

Apr-20

May-20

Jun-20

Jul-20

Aug-20

Sep-20

Oct-20

Nov-20

Dec-20

Jan-21

Feb-21

Mar-21

 
                           

New Facility Customers

0

0

0

0

0

5000

5000

5000

5000

5000

5000

5000

 

Retained Facilities

0

0

0

0

0

0

5000

10000

15000

20000

25000

30000

 

Total Facility Customers

0

0

0

0

0

5000

10000

15000

20000

25000

30000

35000

35,000

Kits Consumed

0

0

0

0

0

15,000,000

30,000,000

45,000,000

60,000,000

75,000,000

90,000,000

105,000,000

420,000,000

We are not resting our laurels with our GenViro development. Later product entries will be test methods for Polio, Ebola (Marburg), Bird Flu, and SARS. The cost of our test kits will be sold in a price range of $4.95 to $7.95 per use. The Coronavirus kit will be sold for $6.95. Each kit sold will carry enough diagnostic for two tests, a primary test, and a test in reserve in case of human error in administrating the primary test. We plan to provide our diagnostics initially for use at hospitals, doctors' offices, and clinics. Once production ramps up, we will offer testing kits and meters to patients for testing at-home.

Mr. Berman concluded, "As you might imagine with a product announcement of such importance, we have been contacted by a number of potential partners for our kit, as well as companies who were not chosen last time to proceed past the proposition stage. The company's first choice for partnering will be a company that made "the cut" last time for our GenUltimate! TBG product. We will discuss partnering potential in a coming release. For the moment, the company is content calling on big box and long term care chains through its existing distributors and agents."

DECN also markets its PetSure! test strip for the diabetic testing of dogs and cats, a diagnostic specifically designed to run on the market leding Zoetis Alpha Trak meter system as well as the GenUltimate! 4Pets Test strip and Avantage! meter. The company has also just introduced its GenExpidient! Universal Translator for bio-sensor devices of different manufacture. A GenExpidient! device will be included in every Covid19 kit. Having such a device will lower the incidence of cleaning and disinfecting the GenViro! meter.

ABOUT DECISION DIAGNOSTICS CORP

Decision  

Forward-Looking Statements:

This release contains the company's forward-looking statements which are based on management's current expectations and assumptions as of March 11 2020, regarding the company's business and performance, its prospects, current factors, the economy, and other future conditions and forecasts of future events, circumstances, and results.

CONTACT INFORMATION:

Decision Diagnostics Corp.
Keith Berman (805) 446-2973

info@decisiondiagnostics.co
www.genultimate.com
www.genultimatetbg.com
www.petsureteststrips.com
www.pharmatechdirect.com

SOURCE: Decision Diagnostics Corp.



View source version on accesswire.com:
https://www.accesswire.com/579985/DECN-Provides-First-Looks-At-Its-GenViroTM-Corona-Virus-Screening-Kit-First-Year-Product-Forecast-of-420-Million-Kits-with-Sales-Beginning-Late-3Q-2020


 

SEC Charges Biotech Company and CEO With Fraud Concerning COVID-19 Blood Testing Device
FOR IMMEDIATE RELEASE

2020-327

Washington D.C., Dec. 18, 2020 —
The Securities and Exchange Commission today announced charges against California-based biotechnology company Decision Diagnostics Corp. and its CEO, Keith Berman, with making false and misleading claims in numerous press releases that the company had developed a working, break-through technology that could accurately detect Covid-19 through a quick blood test. The SEC temporarily suspended trading in Decision Diagnostics' securities on April 23, 2020.

The SEC's complaint alleges that Decision Diagnostics and Berman seized upon the global pandemic through a series of press releases that falsely claimed Decision Diagnostics had developed a finger prick blood test that could detect Covid-19 in less than a minute. According to the complaint, from March 2020 to at least June 2020, Decision Diagnostics and Berman made false and misleading statements about the existence of Decision Diagnostics' Covid-19 device and progress towards FDA emergency use authorization. As alleged, at the time of these claims, Decision Diagnostics lacked a proven method for detecting the virus and had no physical testing device. Further, its advisors had warned that the testing kit they were trying to manufacture would not work as Decision Diagnostics had described. The complaint also alleges that the statements created the misleading impression that the test was soon to be introduced to the market and led to surges in the price and trading volume of Decision Diagnostics' stock.

"During this unprecedented time, when the need for truthful disclosures concerning Covid-19 tests is of vital importance, Decision Diagnostics and its CEO allegedly misled investors by claiming to have made a working test device when all they had was an idea that had not materialized into a product," said Stephanie Avakian, Director of the Division of Enforcement. "With the onset of the global pandemic, we quickly pivoted to identify potential areas of fraud. This case is another example of how the Commission will hold accountable those who exploit the pandemic to harm investors."

"In our complaint, we allege that Decision Diagnostics and Berman repeatedly made baseless representations to the investing public about market-moving events like progress in obtaining FDA approval and having breakthrough technology," said Anita B. Bandy, Associate Director of the Division of Enforcement. "Today's filing is a credit to the dedicated SEC staff, who continued to investigate after the trading suspension and quickly uncovered the alleged fraud."

The complaint, filed in the U.S. District Court for the Southern District of New York, charges Decision Diagnostics and Berman with violating antifraud provisions of the securities laws. The SEC is seeking a court order permanently enjoining both Decision Diagnostics and Berman from directly or indirectly violating those provisions and ordering them to pay civil penalties.

The Department of Justice's Market Integrity and Major Frauds Unit announced today that parallel criminal charges against Berman were also filed in the U.S. District Court for the District of Columbia.

The SEC's investigation, which is continuing, has been conducted by Ernesto Amparo, Carlisle Perkins and Lesley Atkins and supervised by Jeff Leasure and Ms. Bandy with invaluable assistance by Margaret A. Cain of the Office of Market Intelligence and Hane L. Kim of the Microcap Fraud Task Force, both members of the SEC's Coronavirus Steering Committee. The litigation will be handled by James Carlson, David Misler and supervised by Tom Bednar. The SEC appreciates the assistance of the Financial Industry Regulatory Authority.

https://www.sec.gov/news/press-release/2020-327

https://www.sec.gov/litigation/09/complaints/2020/comp-pr2020-327.pdf

 
DECN SECURITY DETAILS

Share Structure

 
Authorized Shares
494,995,000
 
Outstanding Shares

02/14/22 - 380,486,143
11/12/21 - 358,500,583
09/30/21 - 357,780,503
12/17/20 - Berman arrested by FBI

12/11/20 - 349,741,793
11/06/20 - 332,025,278
10/09/20 - 325,752,685
09/11/20 -  313,434,787
08/07/20 - 305,063,608
07/10/20 - 302,663,608
05/15/20 - 267,213,123
04/03/20 - 212,000,000
03/31/20 - 199,792,833
03/06/20 - 159,999,161
12/31/19 - 156,679,161
12/31/18 - 134,551,840
12/31/17 - 110,241,640
12/31/16 - 84,639,908 

 
 
Restricted

07/10/2020 - 5,969,436
10/09/2020 - 9,983,981
12/10/2021 - 18,742,771
 
Unrestricted
12/10/2021 - 339,757,812
02/15/2022 - 361,025,480
 

 

 
 
 
Most Liked Posts
(Last 30 Days)
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
DECN Latest News
  • No Recent News Available for this company!
Most Liked Posts
(Last 30 Days)
New Post